The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
Open accessAbstract
Orphanin FQ (OFQ, Nociceptin) is a recently discovered 17-amino acid neuropeptide that is structurally related to the opioid peptides but does not bind opioid receptors. OFQ has been proposed to act as an anti-opioid peptide, but its widespread sites of action in the brain suggest that it may have more general functions. Here we show that OFQ plays an important role in higher brain functions because it can act as an anxiolytic to attenuate the behavioral inhibition of animals acutely exposed to stressful/anxiogenic environmental conditions. OFQ anxiolytic-like effects were consistent across several behavioral paradigms generating different types of anxiety states in animals (light-dark preference, elevated plus-maze, exploratory behavior of an unfamiliar environment, pharmacological anxiogenesis, operant conflict) and were observed at low nonsedating doses (0.1–3 nmol, intracerebroventricular). Like conventional anxiolytics, OFQ interfered with regular sensorimotor function at high doses (>3 nmol). Our results show that an important role of OFQ is to act as an endogenous regulator of acute anxiety responses. OFQ, probably in concert with other major neuropeptides, exerts a modulatory role on the central integration of stressful stimuli and, thereby, may modulate anxiety states generated by acute stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., et al. (1995) · Nature · doi:10.1038/377532a0 · Cited by 1,912
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
Reinscheid, R. K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., & Civelli, O. (1995) · Science · doi:10.1126/science.270.5237.792 · Cited by 1,821
Self-citationVaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,425
ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization
Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.-L., Moisand, C., Chalon, P., Caput, D., Vassart, G., & Meunier, J.-C. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80235-1 · Cited by 1,077
Ethologically-based animal models of anxiety disorders
Lister, R. G. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90021-s · Cited by 845
Geller, I., & Seifter, J. (1960) · Psychopharmacologia · doi:10.1007/bf00429273 · Cited by 780
Bunzow, J. R., Saez, C., Mortrud, M., Bouvier, C., Williams, J. T., Low, M., & Grandy, D. K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00561-3 · Cited by 607
Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide
Spina, M., Merlo-Pich, E., Chan, R. K. W., Basso, A. M., Rivier, J., Vale, W., & Koob, G. F. (1996) · Science · doi:10.1126/science.273.5281.1561 · Cited by 564
cDNA cloning and regional distribution of a novel member of the opioid receptor family
Fukuda, K., Kato, S., Mori, K., Nishi, M., Takeshima, H., Iwabe, N., Miyata, T., Houtani, T., & Sugimoto, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80603-9 · Cited by 410
cDNA Cloning of an orphan opiate receptor gene family member and its splice variant
Wang, J. B., Johnson, P. S., Imai, Y., Persico, A. M., Ozenberger, B. A., Eppler, C. M., & Uhl, G. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00557-5 · Cited by 381
The neuropsychology of anxiety
Green, S. (1983) · International Journal of Psychophysiology · doi:10.1016/0167-8760(83)90031-4 · Cited by 378
Orphanin FQ is a functional anti-opioid peptide
Mogil, J. S., Grisel, J. E., Reinscheid, R. K., Civelli, O., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00338-7 · Cited by 375
Self-citationChen, Y., Fan, Y., Liu, J., Mestek, A., Tian, M., Kozak, C. A., & Yu, L. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00560-5 · Cited by 333
Corticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324
CCK in animal and human research on anxiety
Harro, J., Vasar, E., & Bradwejn, J. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90020-k · Cited by 274
Wick, M. J., Minnerath, S. R., Lin, X., Elde, R., Law, P.-Y., & Loh, H. H. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90181-3 · Cited by 256
Molecular Cloning of a Novel G Protein‐Coupled Receptor Related to the Opiate Receptor Family
Lachowicz, J. E., Shen, Y., Monsma, F. J., & Sibley, D. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010034.x · Cited by 256
Self-citationPrimary structure and tissue distribution of the orphanin FQ precursor.
Nothacker, H. P., Reinscheid, R. K., Mansour, A., Henningsen, R. A., Ardati, A., Monsma, F. J., Watson, S. J., & Civelli, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8677 · Cited by 253
Self-citationFunctional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ
Mogil, J. S., Grisel, J. E., Zhangs, G., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12917-7 · Cited by 227
Xj, X., Hao, J. ‐., & Wiesenfeld‐Hallin, Z. (1996) · PubMed · Cited by 217
Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats
Pomonis, J. D., Billington, C. J., & Levine, A. S. (1996) · NeuroReport · doi:10.1097/00001756-199612200-00072 · Cited by 210
Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQ
Reinscheid, R. K., Ardati, A., Monsma, F. J., & Civelli, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14163 · Cited by 202
Self-citationBroqua, P., Wettstein, J. G., Rocher, M. N., Gauthier-Martin, B., & Junien, J. L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199504000-00001 · Cited by 198
Knoflach, F., Reinscheid, R. K., Civelli, O., & Kemp, J. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06657.1996 · Cited by 181
Self-citationMurphy, N. P., Ly, H. T., & Maidment, N. T. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00322-3 · Cited by 173
Urocortin, a novel neuropeptide with anxiogenic-like properties
Moreau, J.-L., Kilpatrick, G., & Jenck, F. (1997) · NeuroReport · doi:10.1097/00001756-199705060-00027 · Cited by 170
Self-citationAnxiogenic effects of methyl-β-carboline-3-carboxylate in a light/dark choice situation
Belzung, C., Misslin, R., Vogel, E., Dodd, R. H., & Chapouthier, G. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90006-2 · Cited by 170
RELATIONSHIPS BETWEEN EXPLORATORY BEHAVIOUR AND FEAR: A REVIEW
RUSSELL, P. A. (1973) · British Journal of Psychology · doi:10.1111/j.2044-8295.1973.tb01369.x · Cited by 166
The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion
Devine, D. P., Reinscheid, R. K., Monsma, F. J., Civelli, O., & Akil, H. (1996) · Brain Research · doi:10.1016/0006-8993(96)00476-3 · Cited by 145
Self-citationNociceptin stimulates locomotion and exploratory behaviour in mice
Florin, S., Suaudeau, C., Meunier, J., & Costentin, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00707-8 · Cited by 138
Naloxone sensitive orphanin FQ-induced analgesia in mice
Rossi, G. C., Leventhal, L., & Pasternak, G. W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00578-x · Cited by 121
Cited by
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Mogil, J. S., & Pasternak, G. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01502-3 · Cited by 441
Pharmacology of nociceptin and its receptor: a novel therapeutic target
Calo', G., Guerrini, R., Rizzi, A., Salvadori, S., & Regoli, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703219 · Cited by 437
Metadata
- Authors
- Jenck, F., Moreau, J.-L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., Nothacker, H.-P., & Civelli, O.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-12-23
- Volume
- 94
- Issue
- 26
- Pages
- 14854-14858
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2078867001
- Cited by
- 347
- References
- 34
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.